Founder & CEO, Hertility
Dr Helen O’Neill is a Tenured Lecturer in Reproductive and Molecular Genetics at the Institute for Women’s Health, University College London. She has an MSc in Prenatal Genetics and Fetal Medicine, a PhD in Stem Cell Biology and Developmental Genetics from UCL and has spent the last 15 years researching genetics, fertility and women’s health. Dr O’Neill(MSc, PhD) is CEO and Founder of Hertility, an award-winning women’s health company shaping the future of reproductive healthcare by pioneering unique diagnostic testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause. Hertility provides end-to-end gynaecology care from testing to treatment.